Merge Healthcare to Showcase Merge Mammo(TM) at the 8th Postgraduate College of Radiology

    Imaging organizations report both clinical and financial value of Merge's
    newest multi-modality, vendor-neutral digital mammography workstation

    MILWAUKEE, April 12 /CNW/ -- Merge Healthcare (Nasdaq:   MRGE; TSX: MRG), a
leading medical imaging software and services provider, today announced that
it will showcase its recently-released Merge Mammo(TM) version 7.0 at the 8th
Postgraduate Course of the Society of Breast Imaging, April 14-17, 2007 in
Hollywood, Florida.  One of the industry's first multi-modality,
vendor-neutral digital mammography workstation applications, Merge Mammo(TM)
will be available for demonstration to event attendees, including more than
550 breast-specialized clinicians from around the world.
    (Logo: )
    Merge Mammo enables organizations to display and read images from
different systems simultaneously (digital mammography, ultrasound, MR, CR,
etc.), and to read all breast studies on a single workstation, regardless of
which vendor's acquisition device is used to secure the images.  The solution
helps eliminate challenges associated with changing or adding digital
mammography acquisition devices across an enterprise, and with pulling in
prior studies for comparison from various modalities.  Automation and
customization features enable radiologists to read with the same throughput as
hardcopy.  In addition, Merge Mammo can be interfaced with any existing DICOM-
compliant PACS solution.  Merge Healthcare recently participated in the IHE
North America 2007 Connectathon in the Mammography Image Profile, and passed
for both Image Display and Image Manager/Image Archive.
    "In an era of declining reimbursement, imaging organizations must
identify opportunities to achieve new efficiencies while also staying current
with the latest techniques. Merge Mammo is a one-stop solution for breast
imaging software in a digital environment," says Chris Keefe, chief financial
officer for Metro Imaging, with five locations in the greater St. Louis area.
"With this single workstation, we duplicate our hard-copy review best
practices, streamline workflow, and enhance clinical reading capabilities. 
This supports our organization's priorities to ensure both clinical excellence
and organizational efficiency.  Our transition to digital is saving us money."
    Merge Healthcare is replicating these results at other sites as well.  In
fact, Merge is now offering a new ROI tool to help organizations calculate the
hard and soft cost savings of moving to digital mammography within their
single site or enterprise environment.
    "We are pleased to participate in this year's Society for Breast
Imaging," says Gary Bowers, President of Merge Healthcare's North America
division.  "We look forward to sharing our newest mammography workstation
solution with clinicians and administrators, and to hearing their feedback
about current challenges and opportunities in today's rapidly changing world
of mammography."

    Merge Healthcare is a market leader in the development and delivery of
medical imaging and information management software and services. Our
innovative software solutions use leading-edge imaging software technologies
that accelerate market delivery for our OEM customers, while our end-user
solutions improve our customers' productivity and enhance the quality of
patient care they provide. Merge Healthcare's North American business unit is
focused on accelerating productivity for radiology departments and specialty
practices, imaging centers and hospitals. By combining sophisticated RIS,
PACS, advanced visualization and clinical imaging applications, Merge
Healthcare delivers integrated end-to-end software solutions and professional
services that transform the way our customers interact with referring
physicians, manage their workflow, position their businesses in their markets
and deliver imaging and information services to their customers. For
additional information, visit Merge Healthcare's website at

    Except for the historical information herein, the matters discussed in
this news release include forward-looking statements that may involve a number
of risks and uncertainties. When used in this press release, the words "will,"
"believes," "intends," "anticipates," "expects" and similar expressions are
intended to identify forward-looking statements. Actual results could differ
materially from those expressed in, or implied by, the forward-looking
statements based on a number of factors, including, but not limited to, the
uncertainty created by, the adverse impact on relationships with customers,
potential customers, suppliers and investors potentially resulting from, and
other risks associated with, the changes in the Company's senior management;
costs, risks and effects of the investigation by the Audit Committee of the
Board of Directors; the impact of the restatement of financial statements of
the Company and other actions that may be taken or required as a result of
such restatement; the Company's inability to timely file reports with the
Securities and Exchange Commission; risks associated with the Company's
inability to meet the requirements of The NASDAQ Stock Market for continued
listing, including possible delisting; costs, risks and effects of legal
proceedings and investigations, including the informal, non-public inquiry
being conducted by the Securities and Exchange Commission and class action,
derivative, and other lawsuits; risks in product and technology development,
market acceptance of new products and continuing product demand, the impact of
competitive products and pricing, ability to integrate acquisitions, changing
economic conditions, credit and payment risks associated with end-user sales,
dependence on major customers, dependence on key personnel, and other risk
factors detailed in the Company's filings with the Securities and Exchange
Commission. Except as expressly required by the federal securities laws, the
Company undertakes no obligation to update such factors or to publicly
announce the results of any of the forward-looking statements contained herein
to reflect future events, developments, or changed circumstances, or for any
other reason.

For further information:

For further information: Beth Frost-Johnson, Senior Vice President of 
Marketing of Merge Healthcare, +1-414-977-4254,
Web Site:

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890